Phenotech Multistar

The Phenotech Multistar platform offers game-changing nanomotion technology that slashes the time-to-results for Antibiotic Susceptibility Testing (AST) from days to just 2 hours. It proposes an alternative to the culture-based antibiogram that is growth independent and based on the nanomotion detection of living cells. The high throughput device can simultaneously analyze multiple drugs at one time and is equipped with classification software that provides information on which antibiotic should be used to treat the patient. Phenotech Mutlistar helps physicians save lives by providing personalized and effective treatment in time.

Time To Result (TTR)

Resistell vs most common current solutions

Short blood cultures

Strain ID

AST - antibiotic susceptibility test results

The fastest and most extensible Antibiotic Susceptibility Testing (AST) Platform

Features

Ultra-rapid phenotypic AST independent of bacterial growth
Fixed time to result of exactly 2 hours
Simultaneous analysis of multiple drugs
Easy and automated sample preparation and handling
Modular design enables the analysis of up to 12 patients’ samples simultaneously (one sample per module)
Compatible with diagnostic laboratory workflows
Dedicated data analysis software
User friendly interface

Technology

Cantilever sensors versus superbugs

The Resistell technology platform utilises micro-mechanical sensors to measure nanomotion of living cells. The oscillations of bacteria at the nanoscale are compared before and after the use of antibiotics. When the bacteria cease to move, it means that the antibiotic has eliminated it and is therefore effective. The platform employs advanced machine learning (ML) to develop classification models for different susceptibility phenotypes.

Time To Result (TTR)

Features

Technology

Our patented nanomotion technology platform includes

Hardware

Software